Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLG | P54098 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.48 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.48 |
| ▸ | ALB | P02768 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.48 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.48 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.45 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.45 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.45 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.44 |
| ▸ | POLA1 | P09884 | 1/20 | 0.43 |
| ▸ | ST6GAL1 | P15907 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23157216 | 1.00 | POLG (0.55) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL23157013 | 1.00 | POLG (0.55) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL21895844 | 1.00 | POLG (0.55) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL543711 | 0.93 | POLG (0.49) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL543438 | 0.91 | POLG (0.67) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL21626043 | 0.91 | POLG (0.51) | POLGPOLBLMNAPDE3ACACNA1F | |
| SCHEMBL6913592 | 0.90 | POLG (0.49) | POLGPOLBLMNAPDE3ACACNA1F | |
| Ddctp SCHEMBL16807754 | 0.90 | POLG (0.70) | POLGPOLBLMNAPDE3ACACNA1F | |
| Ddctp SCHEMBL18840498 | 0.90 | POLG (0.70) | POLGPOLBLMNAPDE3ACACNA1F | |
| Ddctp SCHEMBL30586989 | 0.90 | POLG (0.70) | POLGPOLBLMNAPDE3ACACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014031954-A1 | HOMOPOLYMER MEDIATED NUCLEIC ACID AMPLIFICATION | TUFTS UNIVERSITY (US) | 2014-02-27 | — | — | WO | claimed |
| US-6498036-B1 | Methods of targeting a chromosomal gene sequence in a eukaryotic cell | TRUSTEES OF AMHERST COLLEGE | 2002-12-24 | — | — | US | claimed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025059808-A1 | METHOD AND KIT FOR HIGH-THROUGHPUT TAGGING OF CELL NUCLEIC ACID MOLECULES | 中国科学院北京基因组研究所(国家生物信息中心) | 2025-03-27 | — | — | WO | disclosed |
| CN-118647729-A | Methods and kits for high throughput labeling of cellular nucleic acid molecules | 中国科学院北京基因组研究所(国家生物信息中心) | 2024-09-13 | — | — | CN | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| CN-118005706-A | Preparation method of 2',3' -dideoxynucleotide | 天津奥利芙生物技术有限公司 | 2024-05-10 | — | — | CN | disclosed |
| WO-2024073568-A2 | EVOLUTION OF FLUOROGENIC SENSORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| WO-1994009003-A1 | SAPPHYRIN DERIVATIVES, CONJUGATES AND POLYMERS THEREOF AND EXPANDED PORPHYRIN CHROMATOGRAPHIC SUPPORTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-04-28 | — | — | WO | disclosed |
| US-5223263-A | Viricide complex; aids therapy | VICAL, INC. (US) | 1993-06-29 | — | — | US | disclosed |
| WO-1992022306-A1 | TRANSFORMED ERYTHROCYTES, PROCESS FOR PREPARING THE SAME, AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | COMMUNAUTE ECONOMIQUE EUROPEENNE (CEE) (LU) | 1992-12-23 | — | — | WO | disclosed |
| EP-0517986-A1 | Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions | COMMUNAUTE ECONOMIQUE EUROPEENNE (CEE) (LU) | 1992-12-16 | — | — | EP | disclosed |
| WO-1990000555-A1 | LIPID DERIVATIVES OF ANTIVIRAL NUCLEOSIDES, LIPOSOMAL INCORPORATION AND METHOD OF USE | VICAL, INC. (US) | 1990-01-25 | — | — | WO | disclosed |
| EP-0350287-A2 | Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use | NeXstar Pharmaceuticals, Inc. (US) | 1990-01-10 | — | — | EP | disclosed |
| WO-1988007854-A1 | NEW ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEM | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1988-10-20 | — | — | WO | disclosed |
| EP-0286418-A1 | Anti-retroviral agents and delivery systems for the same | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1988-10-12 | — | — | EP | disclosed |
| EP-0284405-A2 | Anti-viral compounds, dosage forms and methods | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1988-09-28 | — | — | EP | disclosed |